BRIEF-Evogene Q3 loss per share $0.20

* Evogene Ltd - ‍in 2018, Evogene expects net cash usage of $14 million to $16 million
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.